Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Other Non Operating Income: 2020-2024

Historic Other Non Operating Income for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to $41,000.

  • Prime Medicine's Other Non Operating Income rose 153.01% to $44,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $142,000, marking a year-over-year decrease of 2.74%. This contributed to the annual value of $41,000 for FY2024, which is 85.04% down from last year.
  • Latest data reveals that Prime Medicine reported Other Non Operating Income of $41,000 as of FY2024, which was down 85.04% from $274,000 recorded in FY2023.
  • Prime Medicine's 5-year Other Non Operating Income high stood at $1.9 million for FY2022, and its period low was $12,000 during FY2021.
  • In the last 3 years, Prime Medicine's Other Non Operating Income had a median value of $274,000 in 2023 and averaged $739,333.
  • As far as peak fluctuations go, Prime Medicine's Other Non Operating Income slumped by 90.48% in 2021, and later spiked by 15,758.33% in 2022.
  • Prime Medicine's Other Non Operating Income (Yearly) stood at $126,000 in 2020, then crashed by 90.48% to $12,000 in 2021, then soared by 15,758.33% to $1.9 million in 2022, then slumped by 85.60% to $274,000 in 2023, then plummeted by 85.04% to $41,000 in 2024.